Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077116
Status:
COMPLETED
Last Update Posted:
2012-07-16
First Post:
2004-02-10
Brief Title:
Idarubicin Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Sponsor:
Organization:
European Organisation for Research and Treatment of Cancer - EORTC